Sun Pharma Advanced Research Company Ltd.

₹115.2

-5 (-4.2%)

SPARC Share Price

Pharmaceuticals & Biotechnology

As on March 19, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 3,740 Cr

P/E Ratio-10.83

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	116.25	Bearish
10-DMA	119.86	Bearish
20-DMA	123.71	Bearish
50-DMA	129.42	Bearish
100-DMA	133.05	Bearish
200-DMA	140.57	Bearish

Historical Performance

1 Year

-11.6%

3 Years

-32.5%

5 Years

-25.1%

10 Years

-60.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023
Sales	---	---	---
Operating Expenses	1,145	1,402	1,803
Other Income	18	295	109
Operating Profit	-3,213	-3,726	-2,032
Interest	90	17	76
Depreciation	124	125	118
Profit Before Tax	-3,428	-3,868	-2,226
Consolidated Net Profit	-3,425	-3,872	-2,226
Adjusted EPS	-11	-12	-7

Compounded Sales Growth

10 Years:-14.4

5 Years:-1.4

3 Years:-12.2

TTM:-1

Compounded Profit Growth

10 Years:54.3

5 Years:2

3 Years:11.2

TTM:-2.3

Stock Price CAGR

10 Years:-9

5 Years:-5.6

3 Years:-11.2

TTM:-20.3

Return on Equity

10 Years:-3

5 Years:-5.8

3 Years:-6.9

last year:-10.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023
Share Capital	325	325	325
Total Reserves	-2,494	933	4,803
Long-Term Borrowings	---	---	---
Total Non-Current Liabilities	1,759	1,230	1,384
Other Current Liabilities	942	619	241
Short Term Borrowings	1,582	470	1
Total Liabilities	3,332	5,138	8,301
Capital Work in Progress	6	13	19
Long Term Loans & Advances	1,282	677	648
Currents Investments	---	18	2,909
Short Term Loans and Advances	40	545	158
Total Current Assets	262	2,694	4,550
Total Assets	3,332	5,138	8,301
Adjusted Book Value	-7	4	16

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -10.83, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -11.2%, indicating poor shareholder returns.
The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
In the last financial year, the company reported a negative or negligible EBITDA of ₹-3255 million, indicating weak operating profitability.
In the previous financial year, the company generated revenue of ₹718 million, indicating a relatively small business scale.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 797287

No. of Shares: 6921 (Approx)

Performance:-20.3%

P/L: ₹-202713

NIFTY Performance: -0.8%

1 day Top Gainers